Austin, TX 12/7/2007 12:14:17 AM
Speak with other shareholders about: (OTCBB: UTUC), (NASDAQ: ADLR), (OTCBB: WWEI).
Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the Chat Live button at the top.
----------------------------------------------------------
Chat real-time with other investors about this UTUC news release,
by clicking this link: http://www.stockwire.com/UTUC
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=UTUC
Utah Uranium Corp. (OTCBB: UTUC) up 10.4% on 509,000 shares traded.
Utah Uranium Corporation is a Moab, Utah-based junior exploration and development company focused on both the systematic exploration of the Henry Mountain Basin, in concert with the acquisition of past producing uranium mines that can be brought back into production in the near term with low capital expenditure. On Dec. 4th 2007, the company was pleased to announce it has signed an Agreement for the acquisition of a 100% interest in a 12 claim license package consisting of 2 past producing Uranium - Vanadium mines known as the "Marcas" and the "Ray Marie."
----------------------------------------------------------
Chat real-time with other investors about this ADLR news release,
by clicking this link: http://www.stockwire.com/ADLR
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=ADLR
Adolor Corporation (NASDAQ: ADLR) up 19.4% on 8 million shares traded.
Adolor Corporation is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. Entereg(R) (alvimopan) is Adolor's lead product candidate under development for the management of the gastrointestinal side effects associated with opioid use. On Dec. 5th 2007, Pfizer Inc. and Adolor Corporation announced an exclusive worldwide collaboration to develop and commercialize novel compounds, ADL5859 and ADL5747, for the treatment of pain. Both compounds are proprietary Delta opioid receptor agonist candidates with the potential to treat a wide range of inflammatory, neuropathic and acute pain conditions.
----------------------------------------------------------
Chat real-time with other investors about this WWEI news release,
by clicking this link: http://www.stockwire.com/WWEI
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=WWEI
Welwind Energy International Corp. (OTCBB: WWEI) up 12.5% on 566,000 shares traded.
Welwind Energy International Corp. is committed to providing the best resource option available for renewable energy, protecting our environment, empowering communities, bolstering local economies and respecting the rights of future generations. On Dec. 5th 2007, the company was pleased to announce that the Guangdong Power Grid Corporation has signed a "wind farm grid connection intent agreement" with Welwind after reviewing the Project Feasibility Study Report and The Grid Connection Report. Both reports were independently produced by the Guangdong Electric Power Design Institute.
--------------------------------------------------
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at www.sec.gov and/or the National Association of Securities Dealers (NASDAQ) at www.NASDAQ.com. The NASDAQ has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
We often receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares into the open market.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
